Home・Akciju saraksts・Quest Diagnostics Inc

Quest Diagnostics Inc

Slēgts

SektorsVeselības aprūpe

234.85 -0.1

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

228.1

Max

235.41

Galvenie mērījumi
By Trading Economics
Ienākumi	70M 334M
Pārdošana	148M 3B
P/E Sektora vidējais	24.638 64.641
EPS	3.12
Dividenžu ienesīgums	1.46
Peļņas marža	10.976
Darbinieki	46,000
EBITDA	47M 481M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+7.43% upside

Dividendes
By Acuity
Dividenžu ienesīgums Sektora vidējais	1.46% 2.31%
Nākamie ieņēmumi	2026. g. 20. okt.
Nākamais dividenžu datums	2026. g. 19. okt.
Nākamais Ex dividenžu datums	2026. g. 2. okt.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	2.6B 26B
Iepriekšējā atvēršanas cena	234.95
Iepriekšējā slēgšanas cena	234.85

Ziņu noskaņojums

By Acuity

31%

69%

86 / 340 Rangs Healthcare

Quest Diagnostics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 29. jūl. 20:08 UTC

Correlated Moves

Quest Diagnostics shares are lower amid a broader decline in the Health Care Services sub-sector, reflecting a negative trend seen since Tuesday's close.

2026. g. 28. jūl. 23:01 UTC

Quest Diagnostics Inc shares are higher in after-market trading, maintaining upward momentum amid broader market strength and trading above their 20-day moving average.

2026. g. 27. jūl. 17:26 UTC

News

Quest Diagnostics Inc. shares are higher today, supported by a 10% revenue increase to $3 billion for Q2 and an improved full-year outlook.

2026. g. 24. jūl. 21:21 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of gains over the past three sessions. No specific news was identified.

2026. g. 23. jūl. 10:01 UTC

Quest Diagnostics Inc is higher in pre-market hours, continuing gains from Wednesday's strong performance, despite an earlier pullback during the session.

2026. g. 22. jūl. 23:26 UTC

Quest Diagnostics Inc shares rose in after-market trading, reflecting a notable increase since Wednesday's close amid broader market volatility from geopolitical tensions.

2026. g. 21. jūl. 19:46 UTC

Correlated Moves

Quest Diagnostics Inc shares are lower today, following declines in Labcorp Holdings Inc, which may be impacting overall sentiment for the stock.

2026. g. 20. jūl. 23:02 UTC

Quest Diagnostics Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The stock is below its 20-day moving average.

Salīdzinājums

Cenas izmaiņa

Quest Diagnostics Inc Prognoze

Cenas mērķis

By TipRanks

7.43% augšup

Prognoze 12 mēnešiem

Vidējais 252.7 USD 7.43%

Augstākais 265 USD

Zemākais 232 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Quest Diagnostics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

11 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 11 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Quest Diagnostics Inc — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

86 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.